Compounded semaglutide and Wegovy are not the same product. Wegovy is an FDA-approved brand-name semaglutide medication, while compounded semaglutide is prepared by a compounding pharmacy when prescribed and is not FDA-approved. At Forva, standard compounded semaglutide can be as low as $139 every 4 weeks (about $151 per calendar month), while provider-supervised semaglutide microdose plans can be as low as $99 every 4 weeks (about $107 per calendar month) on a 48-week prepaid plan.
How much do compounded semaglutide and Wegovy cost in 2026?
Forva's compounded semaglutide starts at $199 every 4 weeks (about $216 per calendar month) on a standard 4-week plan, while longer prepaid plans reduce the effective cost of each 4-week cycle. A provider-supervised semaglutide microdose plan can cost as little as $99 every 4 weeks if prescribed.
| Option | 2026 pricing |
|---|---|
| Forva standard compounded semaglutide, 4-week plan | $199 every 4 weeks (about $216 per calendar month) |
| Forva standard, 12-week prepaid | $537 total, $179 every 4 weeks (about $194 per calendar month) |
| Forva standard, 24-week prepaid | $1,014 total, $169 every 4 weeks (about $183 per calendar month) |
| Forva standard, 48-week prepaid | $1,668 total, $139 every 4 weeks (about $151 per calendar month) |
| Forva microdose, 4-week plan | $179 every 4 weeks (about $194 per calendar month) |
| Forva microdose, 12-week prepaid | $417 total, $139 every 4 weeks (about $151 per calendar month) |
| Forva microdose, 24-week prepaid | $714 total, $119 every 4 weeks (about $129 per calendar month) |
| Forva microdose, 48-week prepaid | $1,188 total, $99 every 4 weeks (about $107 per calendar month) |
| Wegovy injection, eligible new self-pay patients | $199/month for the first 2 months |
| Wegovy injection after introductory offer | $349/month for standard pen doses |
As of September 2026, Novo Nordisk advertises $199 per month for the first 2 months of Wegovy injection for eligible new self-pay patients, followed by $349 per month for standard Wegovy pen doses and $399 per month for the highest-dose pen. Eligibility rules and manufacturer pricing programs can change.
Forva's compounded-plan pricing includes the provider review, medication if prescribed, shipping, and ongoing provider support. There is no separate membership fee on compounded plans. Compounded plans bill every 4 weeks, which works out to 13 billing cycles a year rather than 12 calendar months.
What is the difference between compounded semaglutide and Wegovy?
The biggest difference is that Wegovy is an FDA-approved branded medication and compounded semaglutide is not FDA-approved.
Wegovy is manufactured by Novo Nordisk under an FDA-approved application. Its manufacturing process, labeling, dosage forms, indications, and prescribing information have undergone FDA review.
Compounded semaglutide is prepared by a compounding pharmacy for an individual patient when prescribed. The FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.
Compounded semaglutide is not Wegovy, is not a generic version of Wegovy, and should not be presented as an FDA-approved equivalent.
What does a $99 semaglutide microdose plan mean?
Forva's lowest semaglutide price is $99 every 4 weeks on its 48-week prepaid microdose plan, with $1,188 paid upfront.
A microdose plan uses a lower-dose treatment approach that a licensed provider may prescribe when medically appropriate. It is not simply the standard treatment plan sold at a lower price.
Forva also offers microdose options at $179 every 4 weeks, $417 for 12 weeks, and $714 for 24 weeks. Those prepaid options work out to $139 and $119 every 4 weeks respectively.
The licensed provider determines whether a microdose approach, standard compounded semaglutide, a brand-name medication, or another approach is appropriate for the individual patient.
Does Forva only offer compounded semaglutide?
No. Forva can also help eligible patients who prefer an FDA-approved brand-name GLP-1 medication.
If a patient does not prefer the compounded option, a licensed Forva provider can consider an FDA-approved brand-name medication such as Wegovy. If the patient qualifies and the provider determines that the medication is medically appropriate, the provider writes the prescription and sends it to NovoCare Pharmacy, Novo Nordisk's pharmacy. The patient pays Novo Nordisk's self-pay price for the medication directly ($199 a month for the first 2 fills on starting doses, then $349, as of September 2026), and Forva charges a $99/month membership that covers the provider review and ongoing care. The membership does not include medication.
This gives patients a useful choice. Someone may prefer the bundled self-pay pricing of a compounded plan, while someone else may specifically want an FDA-approved brand-name medication. On Forva's brand-name path the medication is purchased directly from the manufacturer's pharmacy at its self-pay price. Both paths are self-pay. Forva does not bill or accept insurance, and the manufacturer's pharmacy does not bill insurance for these products either, so the price is the same regardless of a patient's coverage.
The provider makes the medical decision in either case. Forva does not guarantee that a particular medication will be prescribed.
Patients can review Forva's weight-loss treatment options before starting.
Which option can cost less without insurance?
Forva's prepaid compounded semaglutide options can cost less per calendar month than current Wegovy injection self-pay pricing, although the medications should not be treated as equivalent products.
The Forva standard 48-week plan works out to $139 every 4 weeks, and the provider-supervised microdose 48-week plan works out to $99 every 4 weeks if prescribed.
Novo Nordisk currently advertises Wegovy injection at $199 per month for the first 2 months for eligible new self-pay patients and $349 per month afterward for standard pen doses under its current self-pay program.
For someone whose insurance covers Wegovy, the comparison can be very different. Novo Nordisk states that eligible commercially insured patients may pay as little as $25 per month, subject to program rules and savings limits.
Price should therefore be compared using the patient's actual coverage and preferred treatment approach rather than list price alone.
What does Forva's compounded price include?
Forva's compounded semaglutide price includes the licensed provider review, medication if prescribed, shipping, and ongoing provider support.
There is no separate membership charge on compounded plans. This makes the published amount closer to the patient's total program cost than an advertised medication price that later adds clinical, shipping, or membership charges.
Forva's compounded plans are self-pay, and insurance is not needed or accepted. Forva accepts FSA and HSA cards. Whether a purchase counts as a qualified medical expense is determined by the patient's plan administrator.
The process starts with a short online medical intake. A licensed provider reviews the patient's information and determines whether treatment is appropriate.
If compounded medication is prescribed, it is prepared by a licensed U.S. compounding pharmacy and shipped discreetly to the patient's door.
If the provider determines medication treatment is not appropriate, the patient is not charged for medication.
Patients can start Forva's online weight-loss evaluation.
Is compounded semaglutide FDA-approved?
No. Compounded semaglutide is not FDA-approved.
The FDA states that unapproved compounded GLP-1 medications do not undergo its review for safety, effectiveness, or quality before marketing. The agency recommends obtaining a prescription from a licensed healthcare provider and filling it through a state-licensed pharmacy.
The FDA has also warned against telehealth sellers that claim compounded medication is the same as an FDA-approved drug. That is why it is important to distinguish clearly between compounded semaglutide and Wegovy.
Forva's licensed providers determine eligibility and the appropriate treatment for each patient. Results vary.
How should a patient choose between compounded semaglutide and Wegovy?
A patient should consider FDA approval, actual out-of-pocket cost, insurance coverage, preferred treatment format, and the licensed provider's medical recommendation.
A patient who specifically wants an FDA-approved brand-name product may prefer Wegovy. If medically appropriate, Forva's providers can prescribe Wegovy and send the prescription to NovoCare Pharmacy; the patient pays Novo Nordisk's self-pay price for the medication directly, plus Forva's $99/month membership for provider review and ongoing care.
A self-pay patient who is open to compounded medication and prioritizes predictable bundled pricing may prefer Forva's compounded semaglutide plans, including provider-supervised microdose options starting as low as $99 every 4 weeks on the 48-week prepaid plan.
Forva can therefore support either path when medically appropriate rather than requiring every patient to choose compounded treatment.
This article is for general information and is not medical advice. Eligibility and treatment decisions are made by a licensed provider.